Background
The Global Cancer Observatory (GCO) is an interactive online platform developed and maintained by the International Agency for Research on Cancer (IARC), a specialized cancer research agency of the World Health Organization (WHO).
It serves as the world’s most comprehensive source of global cancer statistics, providing country-wise estimates and projections to support cancer surveillance, research and public health policymaking.
Key facts:
- Developed by International Agency for Research on Cancer (IARC)
- IARC is a specialized agency under the World Health Organization (WHO)
- Covers 185 countries
- Provides estimates for 36 major types of cancer
- Used extensively by governments, researchers and health organizations for cancer control planning.
Objectives and Features
The primary objective of the Global Cancer Observatory is to provide reliable and comparable cancer data across countries for evidence-based policymaking.
The platform provides information on:
- Cancer incidence (new cases)
- Cancer mortality (deaths)
- Cancer prevalence
- Survival estimates
- Future cancer burden projections up to 2050
- Trends in cancer incidence and mortality
- Geographic distribution of different cancers
- Risk factors associated with cancer burden.
Major tools available under GCO include:
- Cancer Today – Current estimates of cancer incidence, mortality and prevalence.
- Cancer Tomorrow – Future projections of cancer burden up to 2050.
- Cancer Over Time – Trends in cancer incidence and mortality.
- Cancer Causes – Data on cancers attributable to lifestyle and environmental risk factors.
- Cancer Survival – Comparative survival estimates across countries.
Recent Developments
The Global Cancer Observatory recently released updated GLOBOCAN 2022 estimates, highlighting the growing global burden of cancer.
Major findings include:
- Around 20 million new cancer cases were recorded globally in 2022.
- Nearly 9.7 million cancer-related deaths occurred worldwide.
- Lung cancer remained the most commonly diagnosed cancer globally.
- Cancer cases are projected to rise to 35 million by 2050, mainly due to population growth, ageing and increasing exposure to risk factors such as tobacco use, obesity and alcohol consumption.
The updated estimates also highlight significant inequalities in cancer burden, with low- and middle-income countries facing higher mortality due to limited access to early diagnosis and treatment.
Significance
The Global Cancer Observatory plays a critical role in strengthening cancer surveillance and public health planning worldwide.
Its significance lies in:
- Supporting evidence-based national cancer control programmes.
- Assisting governments in planning screening, diagnosis and treatment services.
- Monitoring progress towards global health targets.
- Identifying regional disparities in cancer burden.
- Supporting research on cancer epidemiology and prevention.
- Helping policymakers allocate healthcare resources more efficiently.
- Facilitating international comparisons of cancer trends and outcomes.
Challenges and Way Forward
Despite being the most comprehensive global cancer database, the Observatory faces several challenges.
Major challenges include:
- Limited availability of high-quality cancer registry data in many low-income countries.
- Variations in cancer registration systems across countries.
- Under-reporting and delayed reporting of cancer cases.
- Differences in diagnostic capacity and healthcare infrastructure.
- Need for regular updating of national cancer registries.
To improve global cancer surveillance, countries should:
- Strengthen population-based cancer registries.
- Improve digital health and cancer reporting systems.
- Enhance international collaboration in cancer surveillance.
- Invest in early screening and diagnostic infrastructure.
- Use GCO data for evidence-based cancer prevention and control policies.
The Global Cancer Observatory has become an indispensable tool for understanding the evolving global cancer burden and guiding national and international strategies for cancer prevention, early detection and treatment.
